Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, Tatva Chintan Pharma Chem has informed that a meeting of the Board of Directors of the company is scheduled to be held on Wednesday, 24th July 2024, to consider, approve and take on record the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended 30th June 2024. Further, in accordance with the Company's Code of Conduct for Prohibition of Insider Trading, the Company has intimated its ‘designated persons’ regarding the closure of the Trading Window for trading in the Company's equity shares from 01 July 2024 till the expiry of 48 hours from the date the said financial results are made public. The above information is also being made available on the website of the Company at www.tatvachintan.com.
The above information is a part of company’s filings submitted to BSE.
